scispace - formally typeset
D

David Cohen

Researcher at Northwick Park Hospital

Publications -  58
Citations -  2219

David Cohen is an academic researcher from Northwick Park Hospital. The author has contributed to research in topics: Stroke & Randomized controlled trial. The author has an hindex of 20, co-authored 54 publications receiving 1714 citations. Previous affiliations of David Cohen include London North West Healthcare NHS Trust & Nottingham City Hospital.

Papers
More filters
Journal ArticleDOI

A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM

TL;DR: In this paper, the authors assess prospectively the relationship between microalbuminuria and mortality in a geographically defined population of NIDDM patients and determine the relative importance of micro albuminuria as a risk factor for mortality.
Journal ArticleDOI

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

Duncan Wilson, +203 more
- 01 Jun 2018 - 
TL;DR: Large-scale collaborative observational cohort analyses are needed to refine and validate intracranial haemorrhage risk scores incorporating cerebral microbleeds to identify patients at risk of net harm from oral anticoagulation.
Journal ArticleDOI

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, +1271 more
- 19 Jan 2019 - 
TL;DR: Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures and these results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function.